CytoSorbents Corp (CTSO)
4.58
-0.07 -1.51%
NASDAQ
Jan 17, 20:00
Delayed 2m
USD
CytoSorbents Debt to Equity Ratio:
2.23 for Sept. 30, 2019View 4,000+ financial data types
Browse...
View Full Chart
Debt to Equity Ratio Chart
Export Data
Save Image
Print Image
For advanced charting, view our full-featured
Fundamental Chart
Historical Debt to Equity Ratio Data
View and export this data going back to 2005.
Start your Free Trial
Export Data
Date Range:
| Data for this Date Range | |
|---|---|
| Sept. 30, 2019 | 2.23 |
| June 30, 2019 | 0.8654 |
| March 31, 2019 | 0.6637 |
| Dec. 31, 2018 | 0.587 |
| Sept. 30, 2018 | 0.4941 |
| June 30, 2018 | 0.4589 |
| March 31, 2018 | 0.6832 |
| Dec. 31, 2017 | 0.9736 |
| Sept. 30, 2017 | 1.052 |
| June 30, 2017 | 1.256 |
| March 31, 2017 | -3.137 |
| Dec. 31, 2016 | 3.672 |
| Sept. 30, 2016 | 3.551 |
| June 30, 2016 | 1.253 |
| March 31, 2016 | 0.00 |
| Dec. 31, 2015 | 0.00 |
| Sept. 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| Dec. 31, 2014 | 0.00 |
| Sept. 30, 2014 | 0.00 |
| June 30, 2014 | -0.0768 |
| March 31, 2014 | -0.2379 |
| Dec. 31, 2013 | -0.1153 |
| Sept. 30, 2013 | -0.1147 |
| June 30, 2013 | -0.0692 |
| March 31, 2013 | 0.00 |
| Dec. 31, 2012 | -0.0797 |
| Sept. 30, 2012 | 0.8163 |
| June 30, 2012 | 2.002 |
| March 31, 2012 | 2.143 |
| Dec. 31, 2011 | -0.0565 |
| Sept. 30, 2011 | 0.4129 |
| June 30, 2011 | 0.2746 |
| March 31, 2011 | 0.429 |
| Dec. 31, 2010 | -2.223 |
| Sept. 30, 2010 | -0.9398 |
| June 30, 2010 | -0.6354 |
| March 31, 2010 | 0.4696 |
| Dec. 31, 2009 | 0.00 |
| Sept. 30, 2009 | 0.00 |
| June 30, 2009 | 0.0575 |
| March 31, 2009 | 0.03 |
| Dec. 31, 2008 | 0.0212 |
| Sept. 30, 2008 | 0.0173 |
| June 30, 2008 | 0.0171 |
| March 31, 2008 | -0.1583 |
| Dec. 31, 2007 | 0.00 |
| Sept. 30, 2007 | 0.00 |
| June 30, 2007 | 0.00 |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
About Debt to Equity Ratio
Leverage ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. A low debt to equity ratio indicates lower risk, because debt holders have less claims on the company's assets. A debt to equity ratio of 5 means that debt holders have a 5 times more claim on assets than equity holders.
A high debt to equity ratio usually means that a company has been aggressive in financing growth with debt and often results in volatile earnings.
It is also known as Debt/Equity Ratio, Debt-Equity Ratio, and D/E Ratio.
Learn More
Advertisement
Debt to Equity Ratio Benchmarks
| Benchmarks | |
|---|---|
| BioTelemetry Inc | 0.5421 |
| Delcath Systems Inc | -0.1062 |
| Quest Diagnostics Inc | 0.7124 |
Debt to Equity Ratio Range, Past 5 Years
| Minimum | -3.137 | Mar 2017 |
| Maximum | 3.672 | Dec 2016 |
| Average | 0.7686 |
News
CytoSorbents Reports Preliminary 2019 Financial Results and Issues Stockholder Letter
PR Newswire 01/14 09:30 ET
PR Newswire 01/14 09:30 ET
CytoSorbents to Present at the Piper Jaffray 31st Annual Healthcare Conference
PR Newswire 12/02 07:45 ET
PR Newswire 12/02 07:45 ET
CytoSorbents Pauses Study Enrollment on Committee Recommendation; Shares Tumble Pre-Bell
MT Newswires 11/25 09:16 ET
MT Newswires 11/25 09:16 ET
Advertisement
